Drug intelligence / Profile preview

Qi-Fang-Xi-Bi-Granules

Development stage
Unknown
Lead developer
Huadong Hospital, Fudan University
Administration
Oral
01

Overview

Qi-Fang-Xi-Bi-Granules (QFXBGs) is a traditional Chinese herbal medicine formulation developed by Huadong Hospital Affiliated to Fudan University and the Spine Research Institute for the treatment of knee osteoarthritis. The formulation contains a combination of herbal and chemical components, including *Astragalus mongholicus*, tetrandrine methiodide, *Cyathula capitata*, ground beetle, *Rhizoma Atractylodis*, *Radix Angelica Sinensis*, and *Herba Epimedii*. Preclinical and clinical evidence suggests that QFXBGs alleviate joint degeneration by promoting the methylation of the promoter region of the CCAAT/enhancer-binding protein alpha (C/ebpα) gene, an epigenetic mechanism that helps maintain cartilage thickness and chondrocyte morphology. It is administered orally as granules and is currently commercially available in China, having been used in clinical practice for over two decades.

Other names
Qi-Fang-Xi-Bi
02

Targets

FMR1 (Fragile X messenger ribonucleoprotein 1)CEBPA (CCAAT enhancer-binding protein alpha)

Beyond the preview

Go deeper on Qi-Fang-Xi-Bi-Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qi-Fang-Xi-Bi-Granules.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call